日本儿童侵袭性无乳链球菌的候选疫苗靶点流行率与基因组特征
该研究对2004至2023年日本35家医院237株≤15岁儿童无菌部位侵袭性无乳链球菌分离株进行全国多中心回顾性基因组监测。六价多糖疫苗估算覆盖率为98.3%,GBS-NN/NN2蛋白疫苗为94.9%;红霉素和克林霉素耐药率分别为61.2%和43.5%。CC17克隆中78.7%仅含PI-2B并携带ermB和tetO,提示多重耐药克隆流行,且ST17和ST23谱系存在院内传播和持续区域循环证据。
要点
- 六价多糖疫苗和GBS-NN/NN2蛋白疫苗估算覆盖率分别为98.3%和94.9%。
- 红霉素和克林霉素耐药率分别为61.2%和43.5%。
- CC17克隆以PI-2B+/ermB+/tetO+多重耐药株为主,占78.7%。
核心结论
- 当前母体GBS候选疫苗对日本儿童侵袭性感染可提供广泛覆盖。
- 持续存在且区域播散的谱系提示需研究包括环境储库在内的潜在传播途径。
研究设计与样本
- 全国多中心回顾性基因组监测研究,纳入2004至2023年日本35家医院≤15岁儿童无菌标本分离的237株GBS。
- 采用血清分型、抗菌药物敏感性试验和全基因组测序。
主要发现
- 六价多糖疫苗估算覆盖率为98.3%,GBS-NN/NN2蛋白疫苗为94.9%。
- 红霉素耐药率为61.2%,克林霉素耐药率为43.5%。
- 75株CC17分离株中59株(78.7%)仅含PI-2B并同时携带ermB和tetO。
- 基于单核苷酸多态性的分析显示ST17和ST23谱系存在院内传播和持续区域循环证据。
关键数值与推荐
- 六价多糖疫苗估算覆盖率98.3%。
- GBS-NN/NN2蛋白疫苗估算覆盖率94.9%。
- 红霉素耐药率61.2%,克林霉素耐药率43.5%。
- CC17分离株中仅含PI-2B且携带ermB和tetO者占78.7%(59/75)。
临床怎么用
- 评估母体GBS疫苗对儿童侵袭性感染的潜在覆盖时,可参考本研究中两种候选疫苗的估算覆盖率。
- 关注CC17多重耐药克隆及ST17、ST23谱系的持续传播,提示需加强分子监测和传播途径调查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Streptococcus agalactiae (Group B Streptococcus, GBS) is a leading cause of invasive neonatal and infant infections, including sepsis and meningitis. This study aimed to estimate the vaccine coverage and characterize the genomic features of pediatric invasive GBS in Japan. METHODS: We conducted a nationwide, multicenter, retrospective genomic surveillance study involving 237 GBS isolates from sterile specimens of children aged ≤15 years across 35 hospitals in Japan between 2004 and 2023. Serotyping, antimicrobial susceptibility testing, and whole-genome sequencing were performed. RESULTS: The estimated vaccine coverage was 98.3% for the hexavalent polysaccharide vaccine and 94.9% for the GBS-NN/NN2 protein vaccine. Erythromycin and clindamycin resistance were observed in 61.2% and 43.5%, respectively. Among the 75 CC17 isolates, 59 (78.7%) contained only PI-2B and harbored both ermB and tetO, indicating the predominance of a multidrug-resistant clone. Single nucleotide polymorphism-based analysis revealed evidence of nosocomial transmission and persistent regional circulation, particularly within the ST17 and ST23 lineages. CONCLUSIONS: This study suggests that current maternal GBS vaccine candidates would provide broad coverage for pediatric invasive infections in Japan. The identification of persistent and regionally disseminated lineages highlights the importance of investigating potential, yet, poorly understood, transmission routes, including environmental reservoirs, to inform future prevention strategies.
引用
- Kasai M, Nakano S, Koide S, et al. Prevalence of Candidate Vaccine Targets and Genomic Features of Pediatric Invasive Streptococcus Agalactiae in Japan. J Infect Dis. 2026. PMID: 41065369. doi:10.1093/infdis/jiaf491
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。